Amidst recent market volatility, with the Nifty 50 and Sensex experiencing declines attributed to U.S. tariffs and geopolitical tensions, investors are keenly seeking promising stock opportunities. In this environment, Sagar Doshi, a well-known market analyst, has suggested Alkem Laboratories, Varun Beverages, and Nestle India as potential buys.
Alkem Laboratories
Alkem Laboratories is involved in the development, manufacture, and sale of pharmaceutical and nutraceutical products. Technical indicators suggest a strong buy signal for Alkem, based on daily analysis. The company has demonstrated robust financial performance, with total revenue reaching INR 33,711 million in Q1 FY26, driven by its Branded Generic segment. Alkem is focusing on expanding in non-U.S. markets and enhancing operational efficiency, even as it navigates pricing pressures in the U.S.. For investors holding long positions, maintaining a daily closing stop loss at 5692 is advisable. Fresh short positions could be initiated if the stock closes below this level. The P/E ratio of Alkem Laboratories Ltd is 29.72 times as of January 12, 2026, a discount compared to its peers' median range of 32.79 times.
Varun Beverages
Varun Beverages is a key player in the beverage industry and one of PepsiCo’s largest franchisees globally. The company produces and distributes a wide array of carbonated soft drinks and non-carbonated beverages under PepsiCo trademarks. The company has delivered good profit growth of 41.4% CAGR over the last 5 years. Revenue in 2024 reached ₹200.08 billion, a 24.72% increase from the previous year, while earnings increased by 26.20% to ₹25.95 billion. Goldman Sachs has maintained a 'Buy' rating on Varun Beverages stock, setting a target price of ₹600. The average 12-month price target for Varun Beverages is INR598.96, with 22 analysts recommending a 'buy'.
Nestle India
Nestle India is a subsidiary of the Swiss multinational Nestle, primarily involved in the food business. The company’s product groups include milk products and nutrition, prepared dishes and cooking aids, powdered and liquid beverages, and confectionery. Nestle India has a good return on equity track record, with a 3-year ROE of 107%. The company has also maintained a healthy dividend payout of 82.1%. In 2024, Nestle India's revenue was 201.49 billion, an increase of 3.28% compared to the previous year's 195.10 billion. Earnings were 32.08 billion, an increase of 0.36%. The company has demonstrated good profit growth of 16.09% for the past 3 years.
